Lilly's Patent For ADHD Drug Strattera Found Invalid
A federal judge has sided with generics makers including Teva Pharmaceuticals USA Inc., Mylan Pharmaceuticals and Apotex Inc. and shot down Eli Lilly & Co.'s patent for attention deficit hyperactivity disorder...To view the full article, register now.
Already a subscriber? Click here to view full article